LIPOBLOK Ingredients Favorably Reviewed in Journal Obesity
Century City, CA (PRWEB) July 30, 2013 -- Peter D. Vash, M.D., MPH reports that key ingredients in the proprietary medication LIPOBLOK have been tested in randomized double blind clinical trials and the results have been published in the well-respected academic medical journal Obesity (Volume 21, Number 5, May 2013). The article titled "Efficacy and Tolerability of a Novel Herbal Formulation for Weight Management" can also be found at the U.S. National Library of Medicine, National Institutes of Health. Dr. Vash is pleased that this peer reviewed journal and clinical trial has validated that the ingredients in this new and unique supplement, LIPOBLOK help promote weight loss and the loss of inches from the waist and hip areas. The results show that the participants taking the placebo over an 8 week trial and while on a reduced calorie diet lost 2.94 pounds and 2.51 inches from the waist, while those participants taking LIPOBLOK lost 11.17 pounds and 4.66 inches from their waists over the same time period. No increase in side effects were reported between placebo and LIPOBLOK.
Dr. Vash contends "while this finding is important for the use of an easily available, all natural, non-prescription medication, please keep in mind that this product and every other weight loss product must be used with a reduced calorie diet and increased physical activity if any significant weight loss is to be achieved."
LIPOBLOK is available at http://www.lipoblok.com.
Peter Vash, Metabolic Weight Management Inc., http://www.amatteroffat.com, 13105530804, [email protected]
Share this article